Peak Hours News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Stock

Police questioning man found with gun about UnitedHealth exec killing, reports say

by December 9, 2024
written by December 9, 2024

(Reuters) -Authorities on Monday were questioning a man in central Pennsylvania in connection with last week’s murder of UnitedHealthcare CEO Brian Thompson, several media outlets reported.

Investigators received a tip about the man after he was spotted at a McDonald’s (NYSE:MCD) in Altoona by someone who thought he looked like the suspected killer, CNN reported, citing unnamed officials.

Altoona police found him in possession of a gun, silencer and false identification cards similar to those used by the gunman, according to the network. One of the cards matched the ID used by the suspect to check into a hostel in Manhattan before the shooting, the New York Times (NYSE:NYT) reported.

The man has been arrested on local charges, possibly in connection with presenting a false ID to police, and New York detectives are headed to Altoona, according to the Times. Neither the New York City Police Department nor the Altoona Police Department responded to a request for comment.

Thompson, 50, was gunned down outside a Manhattan hotel early on Wednesday morning by a masked man who appeared to wait for his arrival before shooting the executive from behind.

The suspect, who has not been identified by police, ran from the scene and then rode a bike into Central Park. Surveillance video captured him exiting the park and taking a taxi to a bus station in northern Manhattan, where police believe he used a bus to flee the city.

Thompson, a father of two, had been CEO of UnitedHealth Group (NYSE:UNH)’s insurance unit since April 2021, part of a 20-year career with the company. He had been in New York to attend the company’s annual investor conference.

A UnitedHealth spokesperson declined to comment on the latest reports.

This post appeared first on investing.com

0 comment
0
FacebookTwitterPinterestEmail

previous post
Biogen cut at Jefferies as ‘2025 has a tough setup’
next post
Italy wraps up probe into two Meta execs on alleged $938 million VAT evasion by Facebook owner

You may also like

BASF results down on impairments, restructuring

January 27, 2025

Adani, Ambani news units sue OpenAI over copyright,...

January 27, 2025

China’s DeepSeek sets off AI market rout

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025
Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.









    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      June 7, 2025
    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring

      June 7, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 6, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      June 5, 2025

    Categories

    • Economy (456)
    • Editor's Pick (10)
    • Investing (882)
    • Stock (798)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: peakhoursnews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Back To Top
    Peak Hours News
    • Investing
    • Stock
    • Economy
    • Editor’s Pick